Acceptance of Artificial Intelligence in Supporting Cancer Patients.


Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
29 Jun 2023
Historique:
medline: 3 7 2023
pubmed: 30 6 2023
entrez: 30 6 2023
Statut: ppublish

Résumé

ASCAPE Project is a study aiming to implement the advances of Artificial Intelligence (AI), to support prostate cancer survivors, regarding quality of life issues. The aim of the study is to determine characteristics of patients who accepted to join ASCAPE project. It results that participants of the study mainly originate from higher-educated societies that are better informed about the potential benefits of AI in medicine. Therefore, efforts should be focused on eliminating patients' reluctancy by better informing them on the potential benefits of AI.

Identifiants

pubmed: 37387095
pii: SHTI230561
doi: 10.3233/SHTI230561
doi:

Types de publication

Journal Article

Langues

eng

Pagination

572-575

Auteurs

Ioannis Manolitsis (I)

Second Department of Urology, National and Kapodistrian University of Athens, Sismanogleio General Hospital, Athens, Greece.

Lazaros Tzelves (L)

Second Department of Urology, National and Kapodistrian University of Athens, Sismanogleio General Hospital, Athens, Greece.

Georgios Feretzakis (G)

School of Science and Technology, Hellenic Open University, Patras, Greece.
Sismanogleio General Hospital, Department of Quality Control, Research and Continuing Education, Marousi, Greece.

Dimitris Kalles (D)

School of Science and Technology, Hellenic Open University, Patras, Greece.

Vassilios S Verykios (VS)

School of Science and Technology, Hellenic Open University, Patras, Greece.

Stamatis Katsimperis (S)

Second Department of Urology, National and Kapodistrian University of Athens, Sismanogleio General Hospital, Athens, Greece.

Athanasios Anastasiou (A)

National Technical University of Athens (NTUA).

Dimitrios Koutsouris (D)

National Technical University of Athens (NTUA).

Thanos Kosmidis (T)

CareAcross Ltd, London, United Kingdom.

Charalambos Deliveliotis (C)

Second Department of Urology, National and Kapodistrian University of Athens, Sismanogleio General Hospital, Athens, Greece.

Athanasios Papatsoris (A)

Second Department of Urology, National and Kapodistrian University of Athens, Sismanogleio General Hospital, Athens, Greece.

Ioannis Varkarakis (I)

Second Department of Urology, National and Kapodistrian University of Athens, Sismanogleio General Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH